AIM To evaluate whether pathologically early hepatocellular carcinoma (HCC) exhibited
local tumor progression after radiofrequency ablation (RFA) less often than typical HCC …

Image-guided radiofrequency ablation (RFA) is an evolving and growing treatment option for
patients with hepatocellular carcinoma (HCC) and hepatic metastasis. RFA offers significant …

Background In our previous study, we classified the radicality (R grading) of percutaneous
radiofrequency ablation (RFA) therapy for single hepatocellular carcinoma (HCC) according …

Objective To define an optimal cutoff time to distinguish early and late recurrence in
hepatocellular carcinoma (HCC) patients after radiofrequency ablation (RFA), and to …

AIM: To evaluate outcomes of radiofrequency ablation (RFA) therapy for early hepatocellular
carcinoma (HCC) and identify survival-and recurrence-related factors. METHODS …

Background Radiofrequency ablation (RFA) is related to a high intrahepatic distant
recurrence (IDR) rate, and the associations between IDR and relevant imaging features …

Background Radiofrequency ablation (RFA) is a standard treatment for small inoperable
hepatocellular carcinoma (HCC). Studies on mid-and long-term outcome of RFA as first-line …

Objective Early tumor recurrence, either local or intrahepatic distant recurrence (IDR), after
successful radiofrequency ablation (RFA) for hepatocellular carcinoma (HCC) remains a …

We conducted a retrospective cohort study to investigate the predisposing factors for local
recurrence and complications after percutaneous radiofrequency ablation (RFA) of …

According to the American Association for the Study of Liver Diseases (AASLD) guidelines,
radiofrequency ablation (RFA) is a safe and effective treatment for patients with unresectable …